Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...
Apr 9, 2019
0
22
European surveillance data show a 10 percent decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union ...
Apr 3, 2019
0
2
Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent, according to a study in which the University of Barcelona (UB) took part. The study analysed the efficiency and ...
Mar 14, 2019
0
2
(HealthDay)—Higher intake of whole grains may be associated with a lower risk for hepatocellular carcinoma (HCC) among U.S. adults, according to a study published online Feb. 21 in JAMA Oncology.
Mar 4, 2019
0
10
Hepatitis C is a good news, bad news kind of disease. The bad news is that many with the liver-attacking virus may not even know it. The good news is that once discovered, doctors can effectively treat and even remove it.
Dec 21, 2018
0
1
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF)—a rare condition that can turn fatal within days without liver transplantation—results ...
Nov 13, 2018
0
34
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus (HBV) could be mass-produced for only £24 ($36) per person per year, versus the current UK NHS price of £4,600, and ...
Apr 22, 2015
0
23
(HealthDay)—Doctors should regularly screen people at high risk for contracting the hepatitis B virus, which causes chronic illness and can lead to liver cancer if left untreated, a national panel of health experts has ...
May 27, 2014
0
0
(HealthDay)—Adults at high risk for hepatitis B should be screened for the viral infection, according to a draft recommendation from the U.S. Preventive Services Task Force.
Feb 11, 2014
0
0
A recent discovery by scientists at A*STAR's Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalised treatment ...
Sep 20, 2013
0
0
